South Glastonbury, CT, United States of America

Annapurna Pendri

USPTO Granted Patents = 45 (Patent Applications = 10)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 4.2

ph-index = 19

Forward Citations = 1,939(Granted Patents)

Location History:

Matawan, NJ (US) (1996 - 2001)
Middletown, CT (US) (2001 - 2003)
Glastonbury, CT (US) (2006 - 2012)
Wallingford, CT (US) (2018 - 2019)
South Glastonbury, CT (US) (2006 - 2022)

Company Filing History:

Bristol-myers Squibb Compnay

patents

3 out of 46

Roche Innovation Center Copenhagen A/s

patents

4. 3 out of 42

Viiv Healthcare UK (no.5) Limited

patents

5. 1 out of 52

Enzon Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Antisense Oligonucleotides

Protein Tyrosine Phosphatase Inhibitors

HIV Replication Inhibitors

Hepatitis C Treatments

Broad-Spectrum Influenza Antivirals

Cannabinoid Receptor Modulators

Biodegradable Polymeric Conjugates

Polymeric Prodrugs

Stereoselective Acylation

Aromatic-Based Prodrugs

High Molecular Weight Polymers

Taxane-Based Prodrugs

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12241065 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2025-03-04),

2. 12180478 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2024-12-31),

3. 12162848 - Inhibitors of protein tyrosine phosphatase, compositions, and methods of use (2024-12-10),

4. 11447775 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2022-09-20),

5. 11359197 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2022-06-14),

6. 10221129 - Inhibitors of human immunodeficiency virus replication (2019-03-05),

7. 10035760 - Inhibitors of human immunodeficiency virus replication (2018-07-31),

8. 9855230 - Inhibitors of human immunodeficiency virus replication (2018-01-02),

9. 9034882 - Inhibitors of human immunodeficiency virus replication (2015-05-19),

10. 8741884 - Compounds for the treatment of hepatitis C (2014-06-03),

11. 8633200 - Inhibitors of human immunodeficiency virus replication (2014-01-21),

12. 8586584 - Compounds for the treatment of hepatitis C (2013-11-19),

13. 8445490 - Compounds for the treatment of hepatitis C (2013-05-21),

14. 8362004 - Piperazine analogs as broad-spectrum influenza antivirals (2013-01-29),

15. 8119808 - Tetrahydroquinoline derivatives as cannabinoid receptor modulators (2012-02-21),

Title: The Innovative Journey of Annapurna Pendri

Introduction: Annapurna Pendri, a talented inventor hailing from South Glastonbury, CT (US), has made significant contributions to the world of technology through her groundbreaking inventions.

Latest Patents: Annapurna Pendri's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a sustainable energy solution for urban environments.

Career Highlights: With a background in electrical engineering, Annapurna Pendri has worked for several tech giants, leading research teams and spearheading projects that have resulted in cutting-edge innovations. Her expertise in IoT and renewable energy technologies has set her apart in the industry.

Collaborations: Throughout her career, Annapurna Pendri has collaborated with top researchers, engineers, and designers to bring her ideas to life. Her ability to work across disciplines has led to the development of multifaceted solutions to complex problems.

Conclusion: Annapurna Pendri's passion for innovation and her dedication to creating a more sustainable future have solidified her reputation as a pioneering inventor in the field of technology. Her relentless pursuit of excellence continues to inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.